Opinion: Marylanders should take the following steps to protect themselves from the flu, COVID-19 and RSV this fall, two ...
New research in PLOS Pathogens shows that human cytomegalovirus uses its tegument protein UL35 to trigger proteasomal ...
Morning Overview on MSN
A new antiviral is cleared for herpes sores that standard drugs failed to heal in immunocompromised adults
Pritelivir, sold as Hovilpri, won U.S. approval on October 9, 2026 for one narrow job: clearing mucocutaneous herpes simplex ...
H5N1 hit a Minnesota turkey farm, an Indiana duck facility, and a Texas dairy herd. Why public risk stays low while farm ...
HAMBURG (dpa-AFX) - Drug developer Evotec is standing by its annual forecast, which it lowered in mid-July. Revenue is expected to come in at €570m to €610m, the company said late Tuesday evening.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results